Cargando…
Repeated cross-sectional analysis of hydroxychloroquine deimplementation in the AHA COVID-19 CVD Registry
There is little data describing trends in the use of hydroxychloroquine for COVID-19 following publication of randomized trials that failed to demonstrate a benefit of this therapy. We identified 13,957 patients admitted for active COVID-19 at 85 U.S. hospitals participating in a national registry b...
Autores principales: | Bradley, Steven M., Emmons-Bell, Sophia, Mutharasan, R. Kannan, Rodriguez, Fatima, Gupta, Divya, Roth, Gregory, Gluckman, Ty J., Shah, Rashmee U., Wang, Tracy Y., Khera, Rohan, Peterson, Pamela N., Das, Sandeep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302649/ https://www.ncbi.nlm.nih.gov/pubmed/34302004 http://dx.doi.org/10.1038/s41598-021-94203-7 |
Ejemplares similares
-
TRENDS AND FACTORS ASSOCIATED WITH PROPHYLACTIC ANTICOAGULATION STRATEGIES IN COVID-19: AN ANALYSIS OF THE AHA COVID-19 CVD REGISTRY
por: Lopes, Mathew, et al.
Publicado: (2023) -
Clinical Trial Participation and COVID-19: a Descriptive Analysis from the American Heart Association’s Get With The Guidelines Registry
por: Shah, Kevin S., et al.
Publicado: (2022) -
Machine Learning Outperforms ACC/AHA CVD Risk Calculator in MESA
por: Kakadiaris, Ioannis A., et al.
Publicado: (2018) -
Behavioral and Psychological Aspects of the Physician Experience with Deimplementation
por: McDaniel, Corrie E., et al.
Publicado: (2022) -
Reducing Cost of Care Through Deimplementation of Surgical Overtreatment
por: Nelson, Heidi
Publicado: (2021)